Ann Marie Gelormini

Title: Ann Marie Gelormini: Innovator in Pharmaceutical Chemistry

Introduction

Ann Marie Gelormini is a notable inventor based in Hillborough, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system disorders. With a total of 2 patents, her work has the potential to impact the treatment of various mood and sleep disorders.

Latest Patents

Her latest patents include "Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε." This invention discloses compounds effective as inhibitors of human casein kinase Iε, which are useful in treating central nervous system diseases and disorders. Additionally, she holds a patent for "Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon." This patent also focuses on compounds that can treat similar disorders, showcasing her dedication to advancing medical science.

Career Highlights

Ann Marie Gelormini is currently employed at Aventis Pharmaceuticals Inc., where she continues to innovate and develop new pharmaceutical solutions. Her work is characterized by a strong focus on the therapeutic potential of her inventions.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as William Arthur Metz, Jr. and Frank Halley. These partnerships have likely contributed to her success and the advancement of her research.

Conclusion

Ann Marie Gelormini's contributions to pharmaceutical chemistry are significant, particularly in the realm of treating central nervous system disorders. Her innovative patents and collaborations reflect her commitment to improving healthcare through scientific advancements.